1. Home
  2. AVDL vs EVT Comparison

AVDL vs EVT Comparison

Compare AVDL & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • EVT
  • Stock Information
  • Founded
  • AVDL 2015
  • EVT 2003
  • Country
  • AVDL Ireland
  • EVT United States
  • Employees
  • AVDL N/A
  • EVT N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • EVT Finance Companies
  • Sector
  • AVDL Health Care
  • EVT Finance
  • Exchange
  • AVDL Nasdaq
  • EVT Nasdaq
  • Market Cap
  • AVDL 1.8B
  • EVT 1.9B
  • IPO Year
  • AVDL 1996
  • EVT N/A
  • Fundamental
  • Price
  • AVDL $23.50
  • EVT $24.05
  • Analyst Decision
  • AVDL Buy
  • EVT
  • Analyst Count
  • AVDL 9
  • EVT 0
  • Target Price
  • AVDL $18.06
  • EVT N/A
  • AVG Volume (30 Days)
  • AVDL 5.5M
  • EVT 115.5K
  • Earning Date
  • AVDL 11-04-2025
  • EVT 01-01-0001
  • Dividend Yield
  • AVDL N/A
  • EVT 8.32%
  • EPS Growth
  • AVDL N/A
  • EVT N/A
  • EPS
  • AVDL N/A
  • EVT 6.63
  • Revenue
  • AVDL $248,517,000.00
  • EVT $69,404,302.00
  • Revenue This Year
  • AVDL $64.21
  • EVT N/A
  • Revenue Next Year
  • AVDL $30.80
  • EVT N/A
  • P/E Ratio
  • AVDL N/A
  • EVT $3.55
  • Revenue Growth
  • AVDL 79.88
  • EVT N/A
  • 52 Week Low
  • AVDL $6.38
  • EVT $19.20
  • 52 Week High
  • AVDL $23.57
  • EVT $25.83
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 91.85
  • EVT 40.06
  • Support Level
  • AVDL $18.74
  • EVT $24.03
  • Resistance Level
  • AVDL $19.00
  • EVT $24.79
  • Average True Range (ATR)
  • AVDL 0.25
  • EVT 0.30
  • MACD
  • AVDL 0.20
  • EVT -0.04
  • Stochastic Oscillator
  • AVDL 98.80
  • EVT 8.82

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.

Share on Social Networks: